Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2020
Amgen terminates collaboration with Cytokinetics
Cytokinetics said Amgen elected to terminate their collaboration, effective May 20, 2021.
2020
Cytokinetics announces grant and partnership with HCM Registry
Cytokinetics announced a $1 million grant and a four-year partnership with the HCM Registry, which focuses on improving prediction of risk and outcomes in hypertrophic cardiomyopathy.
2020
Jenscare licenses CK-274 rights for Greater China
Jenscare and Cytokinetics signed an exclusive license agreement for the development and commercialization of CK-274 in Greater China. Jenscare committed to an upfront payment, up to an additional $200 million in development and commercialization milestone payments, and royalties on sales in the licensed territory.